Cyramza 500mg Injection
Marketer
Eli Lilly and Company India Pvt Ltd
Salt Composition
Ramucirumab (500mg)
Overview Cyramza 500mg Injection
Abemaciclib 500mg injection is a cancer treatment drug. It's indicated for non-small cell lung, gastric, and colorectal cancers. Administration is intravenous, by a qualified healthcare provider. Dosage and frequency are determined by your physician, varying based on your condition and potentially adjusted over time. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose may lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, possibly taking weeks or months. Discontinue use only under physician guidance. Elevated blood pressure is a frequent side effect, necessitating regular monitoring. Maintain adequate hydration to mitigate potential diarrhea and headaches. The drug can decrease red blood cell count, mandating routine blood tests throughout treatment.
Uses of Cyramza 500mg Injection
Lung adenocarcinoma, gastric carcinoma, colorectal cancer
Major Benefits of Cyramza 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cyramza 500mg Injection:
- High blood pressure
- Diarrhea
- Headache
- Decreased sodium level in blood
- Anemia (low number of red blood cells)
How to use Cyramza 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cyramza 500mg Injection works:
Ramucirumab 500mg injection is a cancer treatment that inhibits VEGF receptor 2, thus restricting the tumor's blood supply. This action hinders cancer cell proliferation and ultimately leads to their demise.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using alcohol concurrently with a 500mg Cyramza injection. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Cyramza 500mg Injection during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Cyramza 500mg Injection while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by a 500mg injection of Cyramza.
KidneySAFE IF PRESCRIBED
Ramucirumab 500mg injection poses no known safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverSAFE IF PRESCRIBED
Ramucirumab 500mg injection poses no safety concerns requiring dose modification in patients exhibiting hepatic impairment.
What if you forget to take Cyramza 500mg Injection :
NA
Facts to Know About Cyramza 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavioral Class | VEGF inhibitor |
3,018 People bought this recently